Zimbabwe has rejected a major US healthcare agreement valued at $367m (272 million pounds) spanning five years due to Washington's demand for confidential information.
This move became public after a government memo dated December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the deal was "skewed".
An official spokesman has since clarified that the US was requesting health data for scientific study and commercial gain while was not willing to share the resulting advantages from future medical innovations.
"We will now turn to the challenging and unfortunate process of scaling back our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had furnished over $1.9bn for health programmes to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has appealed for more talks to reach a deal suitable to all parties so the country's critical HIV programme can proceed.
Broader Background
This development follows a similar situation in neighbouring Kenya, where a high court suspended a similar health funding agreement following legal challenges were filed about the safety of Kenyans' health data.
Since returning to office last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
USAID had managed assistance for the American government, but Trump claimed its spending was "wasteful" and his administration was pursuing direct bilateral deals to boost openness and responsibility.
According to statements, 16 African countries have so far signed these new health pacts, representing more than $18.3bn of fresh investment.
Details of the Declined Agreement
The funds for Zimbabwe was intended to supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this collaboration would have delivered immense advantages for the people of Zimbabwe, particularly the 1.2 million presently on antiretroviral therapy through American-funded programmes," Tremont added.
However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".
"The proposal required Zimbabwe to surrender its genetic material and health information over an extended period, with no equivalent assurance of access to any scientific breakthroughs – such as new medicines or tests – that could result from that provided information," he stated.
"Effectively, our country would supply the raw materials for scientific discovery without any assurance that the resulting innovations would be available to our population should a new health crisis arise."
Sovereignty and International Frameworks
He also said that the American exit from the global health body and its push of one-on-one health agreements were undermining systems previously established via the global organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system designed to manage potential pandemics.
"This system is designed to ensure that when a nation contributes its samples, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to create them."
These objections regarding the US deal "are not meant as hostility towards the US," he added.
"We are open to further discussions with our US partners on how future co-operation could be structured in a way that respects the sovereignty and dignity of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the official position, but suggested that talks should continue since a large portion of the country's HIV programmes depended on international support.
"In cases where specific concerns exist, such as those relating to data governance or implementation frameworks, these can often be addressed via detailed discussion and negotiated safeguards," it said.
The situation underscores the continuing tensions between accepting much-needed international aid and protecting a country's data in an ever more data-driven world.